82 Rb Tissue kinetics in humans

Author(s):  
Sima Gregg ◽  
Georgia Keramida ◽  
A. Michael Peters
Keyword(s):  
2005 ◽  
Vol 2 (1) ◽  
pp. 24-27
Author(s):  
E.U. Etuk . ◽  
P.A. Onyeyili .
Keyword(s):  

Author(s):  
David S. Chang ◽  
Foster D. Lasley ◽  
Indra J. Das ◽  
Marc S. Mendonca ◽  
Joseph R. Dynlacht
Keyword(s):  

1993 ◽  
Vol 113 (2) ◽  
pp. 181-186 ◽  
Author(s):  
M. Roberto ◽  
A. Favia ◽  
E. Lozupone
Keyword(s):  

2010 ◽  
Vol 245 (1) ◽  
pp. 116-123 ◽  
Author(s):  
Wan-Seob Cho ◽  
Minjung Cho ◽  
Jinyoung Jeong ◽  
Mina Choi ◽  
Beom Seok Han ◽  
...  

2009 ◽  
Vol 53 (10) ◽  
pp. 4086-4095 ◽  
Author(s):  
Michele Di Mascio ◽  
Sharat Srinivasula ◽  
Abesh Bhattacharjee ◽  
Lily Cheng ◽  
Lucia Martiniova ◽  
...  

ABSTRACT Our current knowledge on the antiviral efficacy, dosing, and toxicity of available highly active antiretroviral therapy regimens is mostly derived from plasma or blood kinetics of anti-human immunodeficiency virus (anti-HIV) drugs. However, the blood comprises only 2% of the total target cells in the body. Tissue drug levels may differ substantially from corresponding plasma levels, and drug distribution processes may be characterized by high intertissue variability, leading to suboptimal target site concentrations and the potential risk for therapeutic failures. Positron emission tomography has greatly expanded the scope of the pharmacokinetic measurements that can be performed noninvasively in animal models or humans. We have prepared [18F]FPMPA, a fluorine-18-radiolabeled analogue of tenofovir, to study antiretroviral tissue kinetics in vivo noninvasively and tested the imaging probe in rats. The biodistribution of the fluorine-18 analogue closely follows that of nonfluorinated tenofovir. Compared to that in the blood, the levels of penetration of the antiretroviral drug were found to be significantly reduced in the spleen and submandibular lymph nodes (∼2-fold), in the mesenteric lymph nodes and the testes (∼4-fold), and in the brain compartment (∼25-fold). Intersubject variability of the trough drug concentration (measured at 120 min) in certain tissues, like the colon (coefficient of variation, >100%), is not reflected by the intersubject variability in the blood compartment (coefficient of variation, 24%). Positron emission tomography imaging of the fluorine-18 analogue revealed the accumulation of the antiretroviral drug in the cortex of the kidneys, a potential correlate of tenofovir-induced nephrotoxicity observed in HIV-1-infected treated patients. Thus, [18F]FPMPA is a promising radiotracer for evaluation of tenofovir biodistribution under carefully controlled drug administration protocols.


2007 ◽  
Vol 115 (9) ◽  
pp. 1339-1343 ◽  
Author(s):  
Raymond S.H. Yang ◽  
Louis W. Chang ◽  
Jui-Pin Wu ◽  
Ming-Hsien Tsai ◽  
Hsiu-Jen Wang ◽  
...  

Xenobiotica ◽  
1985 ◽  
Vol 15 (6) ◽  
pp. 485-491 ◽  
Author(s):  
S. Mühlebach ◽  
P. A. Wyss ◽  
M. H. Bickel

Sign in / Sign up

Export Citation Format

Share Document